Evidence map›Paper›PMID 26924712›Full record

ArticleScientific reports2016

Dietary sugar intake increases liver tumor incidence in female mice.

Marin E Healy, Sujoy Lahiri, Stefan R Hargett, Jenny D Y Chow, Frances L Byrne, David S Breen, Brandon M Kenwood, Evan P Taddeo, Carolin Lackner, Stephen H Caldwell and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Systematic identification of single transcription factor perturbations that drive cellular and tissue rejuvenation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Metabolites as signalling molecules.Nature reviews. Molecular cell biology · 2023
    Review
  11. Review
  12. Review
  13. Spot-light on microbiota in obesity and cancer.International journal of obesity (2005) · 2021
    Review
  14. Article
  15. Fructose and the Liver.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Marin E HealyDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Sujoy LahiriDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Stefan R HargettDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Jenny D Y ChowDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Frances L ByrneDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
David S BreenDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Brandon M KenwoodDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Evan P TaddeoDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
Carolin LacknerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Stephen H CaldwellDepartment of Medicine, University of Virginia, Charlottesville, VA, USA.
Kyle L HoehnDepartment of Pharmacology, University of Virginia, Charlottesville, VA, USA.
University of Virginia · USMedical University of Graz · ATUNSW Sydney · AU

Funding

TRAINING IN THE PHARMACOLOGICAL SCIENCEST32GM007055 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LYNCH, KEVIN R. · 1985 to 2022
$7.2M
ACC enzymes and protein acetylationR01DK101803 · NIDDK · UNIVERSITY OF VIRGINIA · PI HOEHN, KYLE LEE · 2014 to 2017
$1.4M
Lipid Metabolism in Ethanol-Stimulated Liver CancerR21AA022154 · NIAAA · UNIVERSITY OF VIRGINIA · PI HOEHN, KYLE LEE · 2014 to 2015
$409k
NIAAA NIH HHS R21 AA022154NIDDK NIH HHS R01 DK101803NIGMS NIH HHS T32 GM007055
6 · The paper itself

Abstract

Overnutrition can promote liver cancer in mice and humans that have liver damage caused by alcohol, viruses, or carcinogens. However, the mechanism linking diet to increased liver tumorigenesis remains unclear in the context of whether tumorigenesis is secondary to obesity, or whether nutrients like sugar or fat drive tumorigenesis independent of obesity. In male mice, liver tumor burden was recently found to correlate with sugar intake, independent of dietary fat intake and obesity. However, females are less susceptible to developing liver cancer than males, and it remains unclear how nutrition affects tumorigenesis in females. Herein, female mice were exposed to the liver carcinogen diethylnitrosamine (DEN) and fed diets with well-defined sugar and fat content. Mice fed diets with high sugar content had the greatest liver tumor incidence while dietary fat intake was not associated with tumorigenesis. Diet-induced postprandial hyperglycemia and fasting hyperinsulinemia significantly correlated with tumor incidence, while tumor incidence was not associated with obesity and obesity-related disorders including liver steatosis, glucose intolerance, or elevated serum levels of estrogen, ALT, and lipids. These results simplify the pathophysiology of diet-induced liver tumorigenesis by focusing attention on the role of sugar metabolism and reducing emphasis on the complex milieu associated with obesity.

Indexed as

Dietary SucroseAdiposityAnimal FeedAnimalsBody WeightCarcinogensDietary FatsDiethylnitrosamineFatty LiverGlucose Tolerance TestHumansIncidenceInsulinLiver NeoplasmsMiceRisk FactorsCarcinogensDietary FatsDietary SucroseDiethylnitrosamineInsulin

Identifiers

PMID26924712
PMCPMC4770276
OpenAlexW2320232432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.